1 / 7

Welcome

Welcome. I n This I ssue Welcome. Dear Colleague,. Balloon Aortic Valvuloplasty. Welcome to the first letter of the New Year from the Heart and Car d iovasc u lar Service Line.

tom
Download Presentation

Welcome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Welcome • InThisIssue • Welcome DearColleague, • BalloonAorticValvuloplasty WelcometothefirstletteroftheNewYearfrom the Heart andCardiovascularServiceLine. TheMedicalCollegeofGeorgiahasa50-yeartraditionoftakingcareofchildrenwithheartproblems.Therefore,itshouldnotcomeasasurprisetoanyonethatthesechildren,nowproductiveyoungadults, looktousforcontinuity oftheircare.Thecardiovascularservice linehasahighlyspecializedteamconsistingofadedicatedcadreofphysicians,nurses,perfusionistsandaparents'grouptotakecareofthesecomplexpatients.SheldonLitwin,M.D.,ProfessorandChiefofCardiologyatGeorgiaRegentsUniversity,hasspecialexpertiseandinterestinthesubjectandhaswrittenanoverviewinthiseditionofthenewsletter.I knowyouwillfinditinterestingand informative. • BloodlessMedicine • AdultCongenitalHeart • Disease • FellowshipHighlights • Conferences MaryArthur,M.D.,AssociateProfessorofAnesthesiology,shareswithusthebenefitsofusingbloodless medicineasanalternative todonorblood.Almostevery week,we discovernew complications andsideeffects ofbloodtransfusions.Assuch,itbehoovesustouseallpossiblemeans tominimizeuseofblood and bloodproductswithout compromisingpatientoutcomes.Iampleasedtoreportthat,owingtoourevidenced­ basedguidelinesandateamofdrivenindividuals,bloodutilizationrates inourcardiac surgerypatientsareoneofthelowestinthecountry. ,_ Asweencounteranincreasingnumberofagedpatients withconcomitantadvanced diseases,wefindourselvesperforming stagedprocedurestoallowthesepatientstimetorecoverfromtheirmultipleproblems.PaulPoommipanit, M.D.writesaboutonesuch temporizing measure,balloonaorticvalvuloplasty,inpatientswithsevereaorticstenosistoo illt·oundergodefinitivesurgery.Aclosecoordinationbetweenvariousspecialistsisessentialforoptimaloutcomes. M.VinayakKamath,M.D. Director,Heart and Asalways,weare proudofourfellowsintrainingand someoftheiractivitiesare outlinedinside.Iamsureyouwillagreethat theyare allmultifacetedandtalentedindividualswithconsiderablepromise. Cardiovascular Servicesand Chief,CardiothoracicSurgery GeorgiaRegents University112015thStreetBA-4300 Augusta,GA30912 706-721-3226 kamath@gru.edu I I. Wehavea busyyear ofCMEactivitiesaheadofus(scheduleattached).Ifyouhave suggestionsfornewtopicsoradifferentformatpleaseletusknow. GHealth GEORGIA REGENTS HEART&CARDIOVASCULAR SERVICES Wishingyouandyours thebestfortheNewYear, M.VinayakKamath,M.D. Director,HeartandCardiovascularServicesandChief,CardiothoracicSurgery

  2. AssistantProfessorof Forpatientswithsevereaorticstenosis,the optionofaless-invasiveprocedureisbecomingmorecommonatGeorgia RegentsMedicalCenter'sHeartandCardiovascularCenter.Subsequently,welearnedthatrestenosiswithinsixmonthsiscommon.Today,balloonaorticvalvuloplasty isincreasinglyusedas a"bridge"tomoredefinitivetherapy. Balloonaorticvalvuloplasty(BAV)increasesthe aorticvalveareabyinflatingaballoonwithinaseverelystenoticaorticvalve.Historically,thisprocedurewasdoneinhopesofprovidingadurable,less-invasivesolutionforaorticstenosis. WiththeadventofTAVR,BAVis beingperformedmorefrequently. tolerateopen-heartsurgeryandthe decision wasmadetoperformBAVas abridgetofutureAVRorTAVR. Thepatientwasbroughttothecardiaccatheterizationlab,graciouslyprovided bythepediatriccardiovascular service.Cardiacanesthesia and hemodynamic support were provided.Transesophageal echocardiography demonstrated avalveareaof0.8-0.9cm2(severeaorticstenosis).Oneballoon inflationwas doneandrepeat echocardiographydemonstratedavalveareaof1.2cm2(moderateaorticstenosis).ThepatientthenhadaSOpercent decreaseinthepressuregradientacrossthevalve.Givenhisothercriticalillnesses,theteamdecidedtoterminate theprocedure.Thepatienthasslowlyrecoveredandisworkingwithphysicaltherapytoimprovehisconditioning. BAVforsevereaorticstenosisisusedtotemporizepriortosurgicalAVR,assessforresponseandasanalternativeinseverelysymptomaticpatientswhoarenotcandidatesforotherproceduressuchasAVRorTAVR.Amultidisciplinary approachatGeorgiaRegentsUniversityinvolvingcardiacanesthesiologists, cardiac surgeons, interventionaI cardiologists and cardiovascular imaging specialistsimprovedthe patient'squality oflife. Sincesurgicalaorticvalvereplacement(AVR)providesadurable,long-lastingsolutionforaorticstenosis,BAVhasinfrequentlybeenperformed.But,withtheadventoftranscatheter aortic valve replacement (TAVR), inwhichanaorticvalvecanbeimplantedpercutaneously, BAVisbeingperformedmorefrequently,providing analternativetreatmentforsevereaorticstenosis.AttheGeorgiaRegentsMedicalHeartandCardiovascularCenter,an84'-year-oldmanwithend-stagerenaldisease recentlyunderwent BAV.Thispatienthascardiomyopathywithanejectionfractionof30 percentandmoderateaortic stenosis.Hepresentedwithanon-STelevationmyocardial infarction,classIVheartfailureandhypotension.Acardiaccatheterization revealedsignificantcoronary arterydiseaseoftherightcoronary arteryand leftanterior descending artery.Surgerywasdeemedtoo riskysincehis EFwasnow20-25percentwithsevereaorticstenosisandseveremitralandtricuspid regurgitation. Thepatientunderwenthigh-riskstentingofhisRCAand LADandthepreviouslyplacedintra-aorticballoonpumpwasremovedthefollowingday.Weekslater,thepatientimproved,butwas stillhavingclassIII-IV heartfailure andreceivingdaily hemodialysiswhilehavirigepisodes ofhypotension.Thispatient wastoo deconditionedto -2-

  3. MaryE.Arthur,M.D. AssociateProfessor,Anesthesiology andPerioperativeMedicine BloodEnhancesOxygen Bloodenhances oxygen-carrying capacity,improveswound-clottingandprovidesvolumesupportforcardiac output.Nevertheless,moreandmorepatientsareseeking safeandeffectivealternativestobloodtransfusionsduringsurgery-evencardiac surgery-becauseofreligiousconvictions, medicalconcerns orpersonal preference. Religious objections tend to be limitedto primarycomponents(packedredbloodcells, plateletsandfresh frozen plasma)whilesecondary componentssuchasalbuminandfactorconcentratesaregenerallyacceptable. Physiciansareincreasinglyaccommodating patients'preferencesforbloodlesssurgerybecauseofmountingevidencethatbloodtransfusionsportendworseoutcomes. Minimizingbleedingandlimitingbloodtransfusions have becomeimportantelementsofquality improvementprograms. Bloodless cardiacsurgicalproceduresrequire specialexpertise, precisemonitoring,state-of-the-artequipmentand innovativetechniques. TheGRUBloodlessMedicineandSurgeryProgramwas designedexpressly forthesereasons. Why dowecare? Concernsregardingthesafetyandefficacyofallogeneic bloodtransfusions,theimpactonpatientoutcomes andtheastounding costsandchallenges associated withmaintaininganadequatesupplyofbloodproductshasrenewed aninterest in alternatives to transfusion. In additiontotransfusion-related riskssuchasinfections I respiratoryfailureandthromboembolic complications,redbloodcelltransfusions mayalter immunefunction, impactinglong-termsurvival. Whatdoweknow? Mostcardiopulmonarybypasspatientshavesufficientwound-clottingafterreversalofheparinanddonotrequire transfusion.Evidencesuggeststhattransfusionsmightnotimprovetheoutcomesofstablenon-bleedingpatientsinnearly90percentofthecommontransfusionscenarios reviewed.Transfusions areonlydeemedappropriateforpatients65andolderwithcomorbiditiesandahemoglobinof<8g/dl. Severaltoolsareavailabletoaccommodatetheneedor preferenceforbloodlesssurgery,coveringallphasesoftheprocedure:preoperative, intraoperativeandpostoperative. Howbigistheproblem? Almost 15millionunits ofpackedredbloodcellsare transfusedannuallyintheUnitedStatesduring surgery, withcardiacoperationsconsuming asmuchas15percent ofthenation'sbloodsupply.Thispercentageisgrowing,largelybecauseoftheincreasingcomplexityofcardiac surgicalprocedures. 1)Patient'sbloodcollected 2)Bloodvolumerestoredusingplasmaexpanders(Albumin,HetastarchorCrystallods). ANHAcuteNormovolemicHemodilution Oneimportantstrategyis acute normovolemichemodilution,aprocessincreasingthevolumeofthepatient's ownstoredbloodusingexpanderssuch asalbumin,hetastarchandcrystalloids.The 1bloodisreturned, tubingremainsconnectedtothepatientat 3) OffCPB, thepatient's alltimes,maintainingaclosedcircuit.The patient'sstoredblood,whichhasallthe connedionmaintains majorclottingfactorsaswellasplatelets,is closedcircut. returnedtothepatientafter weaningfromcardiopulmonarybypass. -3-

  4. How doweinvolvethepatient? Beforesurgery,amemberofthebloodconservationteamgivesthepatientaformlistingallthefactorconcentrates. Thepatientthendecideswhichconcentratescanbeused duringtheprocedure. Our multidisciplinary blood management teamworkstogetherto limitblood transfusions anddecreaseperioperative bleeding while still maintaining safe outcomes.AtGRU,about25 inpatientandoutpatient casespermonthutilizebloodlessmedicinetechniquesacrossallspecialtyareas. Foursuccessfulbloodlesscardiacsurgeryprocedureshavebeendoneinthelastfew months. Morethan 180community members attended aBloodlessMedicineandSurgeryProgramseminarlastfallhighlightingtechniquesthatenablemedicalandsurgicaltreatmentwithoutbloodtransfusions,attestingtotheacuteinterestandgrowingawarenessofthisburgeoningfieldofmedicine.GRUishappytofillthisvitalnicheinthecommunity. Ollrl"U.-\II U">#Aol D ...,":_'"N" -""'·- 90o --- Boo . - - ---- - ..., Cardiovasculardiseaseistheleadingcauseof deathworldwide.Inadditiontoacquireddiseasesassociatedwithaging,heartdiseasecanbepresentfrom birth.Becauseofsteadyadvancesinmedicine,mostpatients withcongenitalheartdiseasetodaysurviveintoadulthoodandmanyhavenormallifespans.Patientswithcongenitalheartproblemsarelikelytobenefitfromconsultationorongoingcarefromacardiovascularclinicianorteamwithspecialinterestortraininginthisarea. Themostcommoncongenitalheart conditionisthebicuspidaorticvalve. B A Themostcommoncongenitalheartconditionisthebicuspidaorticvalve.About1in100peoplehaveabicuspid aortic valve.Theaorticvalvenormallyhasthreedistinctleaflets(Figure1A).Eachleaflet,orcusp,isassociatedwithasinusofValsalva(Figure1C)intheaorticroot.Therightandleftcoronaryarteriesarisefromtherespective right andleftsinusesofValsalva.The noncoronarysinusdoes notgiverisetoacoronaryartery.Thethreeleafletsofthe aorticvalveopentoproduceatriangle-shapedorifice (Figure1A)andwhenclosed,appear likea"Mercedes"sign(Figure 1B).Patientswithbicuspidaorticvalveshave c D -4-

  5. c A B onlytwoleaflets(Figure2Avalve open, Figure28valveclosed).Insomecases,thisresultsfromfusionofthecommissure betweentwoleafletsproducingaraphe(Figure28). Innormal individuals,the cellophane-thinvalveleafletsperform admirably overthecourseof80-plusyears. However, bicuspidvalves produce turbulentflow patternsthat likelycontributeto earlydamageoftheleaflets.Degenerativechangesofthe leaflets,includingprolapseorcalcification(Figure20),maycauseregurgitationorleakage(Figure2E)orstenosis(Figure 2A).Theseconditionstypicallydonotbecome evidentuntiladulthood.Echocardiographyisgenerally performedonadultpatientswithbicuspidvalveseveryonetotwoyearstolookfor regurgitationorstenosis.Oncetheseabnormalitiesbecomeclinicallysignificant,surgicalvalve replacementisusuallyrecommended(Figure3C). D Bicuspidaortic valveisalsolinked toabnormalitiesoftheaorta. Bicuspidaorticvalvealsoisalsolinkedtoabnormalities oftheaorta.Coarctationoftheaorta,anarrowingofthe descendingthoracicaortajust afterthetake-offoftheleftsubclavianartery (Figure3D)occursinupto40 percent ofpatientswithbicuspidvalves.Suchnarrowingshaveanumberofadverseeffects,particularlyhypertensionoftheupperbody.Inadditiontoaorticcoarctation,thewall oftheentireaortamaybeabnormal.Thismaylead toenlargementand/ordissectionoftheascendingaorta. Forthisreason,aorticimagingwithMRIorCTis oftendoneperiodicallyinpatientswithbicuspidvalves(Figure3Aang B).Thenaturalhistoryofpatientswithbicuspidvalvesandaorticenlargementissimilartothatofpatients withMarfan'ssyndrome.Aorticrootreplacementmayberecommendedatthetimeofvalvereplacementsurgery inthosewithbicuspidvalves,orsometimesevenbeforethevalveitselfrequiressurgicalintervention.Angiotensinreceptorblockingagentsareincreasinglybeingusedtoprotecttheaortafromexpansioninpatientswithvarious aortopathies,includingthosewithbicuspidaorticvalves. Beingbornwith2ratherthan3leafletsoftheaorticvalve requires lifelong monitoring.To effectivelydiagnoseandtreatthesignificantvalvularandvascular complicationsthatcanariseinpatientswith bicuspidaorticvalve,referraltocenterswithspecializedinterest inmedicalcare,imagingandsurgicaltherapyforpatients withadultcongenitalheart diseaseisappropriate. B A Figure3.AandB.Twoviewsofaorticrootaneurysm(arrowwith dissectionofdescendingaorta(arrowheads).C.CTimageof mechanicalaorticvalveinopenposition.D.Imageofrepairedaortic coarctationwithnativeaorta (arrow)andgraftgoingaroundcoarct (arrowhead).

  6. FethiBenraouane,M.D. 3rdYear AdultCardiologyFellow JustinMackenzieVining,M.D.2ndYear PediatricCardiologyFellow AminYehya,M.D.3rdYear AdultCardiologyFellow MicheleMurphy,M.D. 1stYear AdultCardiologyFellow laurenHolliday,M.D. 1stYear AdultCardiologyFellow AlbertoMorales-Pabon,M.D.3rdYearChief AdultCardiologyFellow I '( " SyedS.Zaidi,M.D. 2ndYear AdultCardiologyFellow RodEvanPellenberg,M.D. 2ndYear PediatricCardiologyFellow JoseCuellar,M.D.3rdYear AdultCardiologyFellow AdultCardiologyFellowship Highlights PediatricCardiologyFellowshipHighlights August2012 ·AminYehya,M.D.,waselected PresidentoftheHousestaffOrganizationfor2012-13. November2012 ·RodEvanPellenberg,M.D.,submittedthemanuscript, "PapillaryFibroelastomaofTricuspidValveinaPediatricPatient"andwasacceptedto AnnalsofThoracicSurgery. ·RodEvanPellenberg,M.D.,lecturedforfirst-yearmedicalstudents' embryologycourse. ·JustinMackenzieVining,M.D.,wasselectedaGRUFellowRepresentativeNonvotingmemberoftheGeorgiaChapteroftheACC. • October2012 • AminYehya,M.D.,AlbertoMorales-Pabon,M.D.andFethiBenraouane, • M.D.passedtheEchocardiographyBoardsontheirfirstattemptinJuly.This100percentpassrateforourfellowswasalsoassociatedwithsomefellowsscoringinthe901hpercentile. • ·The12adultcardiology fellows completed their first nationwideAmericanCollegeofCardiologyIn-ServiceExam. Overallprogramscore wassignificantlyabovethenationalaverage.The finalyeartraineesscored100pointsabovethenationalaverageforallotherthirdyearcardiology fellowshiptraineesnationally. December2012 ·JustinMackenzieVining,M.D.,wasboardcertifiedingeneralpediatricsbytheAmericanAcademyofPediatrics. 201.3 PediatricFellowshipProgramMatch ThePediatricFellowshipProgramishappytoannouncethematch foranewfellowwhowillstartJuly1,2013. November2012 ·FourofourcardiologyfellowspresentedtheirresearchpostersattheAnnual GeorgiaChapteroftheAmericanCollegeofCardiology. ·LaurenHolliday,M.D.wasselectedto betheFellowRepresentativeNonvotingmember oftheGeorgiaChapteroftheACC. StefaniM.Samples,M.D.-MedicalCollegeofGeorgiaatGRU. 2013 AdultFellowshipProgram Match :"'::oo!!•-· ·Amin Yehya, M.D.,organized thecollectionoftoysfortheJamesBrownToyDriveforlocalneedychildrenattheJamesBrownArenaonDecember20. TheCVDiseaseFellowshipProgramhadahighlysuccessfulmatchfornew fellowswhowillstartJuly1,2013. RebeccaNapier,M.D. -GRUResidencyProgram PratikChoksy,M.D.,M.B.B.S.-GRUResidencyProgramAmudhanJyothidasan,M.D.-UniversityofMassachusettsLorenMorgan,M.D.-UniversityofSouthCarolina report.gru.edu/archives/13424

  7. 'I ! 1 Pleasecontactusformore information 106-72-2136'. - . . . . '" ,, -CME-- LeCtures' . ·, February22 Speaker: MichaelLuc,M.D.,2ndYearGRUCardiologyFellow Topic: "StressTesting" March8 Speaker: SimiKumar,M.D.,1stYear GRUCardiologyFellow Topic: "CardiacCT/CardiacMRI" March15 Speaker: AshkanAttaran,M.D.,/ndYear GRUCardiologyFellow . Topic: March22 Speaker: "ChronicHeartFailure" LaurenHolliday,M.D.,1stYear GRUCardiologyFellow "Intra-aorticBalloonPumps" Topic: March29 May3 Speaker: VincentRobinson,M.D., Program Director,CVDisease Topic: "TheNewACGME" May24 Speaker: FethiBenraouane,M.D., 3rdYear GRUCardiology Fellow Topic: "RecanalizationofChronicallyOccluded Graft:Isit a ParadigmShift? Speaker: AlbertoMorales,M.D.,3rdYear GRUCardiologyFellow Topic: "DiastolicHeartFailure" April12 Speaker: MicheleMurphy,M.D.,1stYear GRUCardiologyFellow "WomenandHeartDisease" Topic: April19 Speaker: Reza Amini,M.D.,2ndYear, GRUCardiologyFellow Topic: "Novel Anticoagulation Therapy" April26 Speaker: JoseCuellar,M.D.,3rdYearGRUCardiologyFellow Topic: "ComprehensiveApproachtoSyncope" CardiovascularConferences ' GRUCoronaryRevascularizationSymposium CardiovascularUpdateforPrimaryCareProviders October26-27,2013·MarriottRiverfront Augusta,GA June6-9,2013 Kiawah Island,SC GRUCardiacConference October9-13,2013ChateauElanBraselton,GA 7

More Related